Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing

Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing

MT newswireMT newswire2026/09/23 21:01
05:01 PM EDT, 09/23/2026 (MT Newswires) -- Jon Faiz Kayyem, Director, on September 23, 2026, executed a purchase for 5,000 shares in Inhibrx Biosciences (INBX) for $500,000. Following the Form 4 filing with the SEC, Kayyem has control over a total of 1,074,046 common shares of the company, with 1,074,046 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2007919/000136626826000011/xslF345X05/wk-form4_1790197155.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Overseas capital is aggressively buying US stocks! Net inflows reached $942 billions over the past 12 months, marking a record since 1985.

According to data from the US Department of the Treasury, in the 12 months ending July this year, overseas investors made net purchases of US stocks totaling $942 billion, marking the highest rolling 12-month total since records began in 1985. The net purchases in the second quarter alone reached $426 billion, setting a new single-quarter record. Meanwhile, overseas demand for US Treasuries has noticeably cooled, with purchase volumes falling significantly. As a result, the US is facing higher costs in government debt financing.

华尔街见闻•2026/09/26 11:36